未登录

Y

Yiming Li

institute of basic medical sciences (ibms)

H指数:15

被引数:747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing the mechanical properties, frost resistance, and microstructure of steel slag powder incorporated roadbeds foamed concrete

评估钢渣粉掺入路基泡沫混凝土的力学性能、抗冻性和微观结构

Construction and Building Materials

IF8

2025-11-080

PRE

Cerebral 18F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-05-020

PRE

T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy

靶向MHC连接NY-ESO-1的靶向T细胞受体的双特异性T细胞接合器用于肿瘤免疫治疗

IF3.9

2024-04-011

OAAI

Superantigen-fused T cell engagers for tumor antigen-mediated robust T cell activation and tumor cell killing

MOLECULAR THERAPY

IF12

2024-02-011

PRE

Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer

CELL DEATH DISCOVERY

IF7

2023-11-020

OAAI

Structure Optimization of 12β-O-?-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy

PHARMACEUTICALS

IF4.8

2023-05-174

OAAI

Regulatory Mechanisms and Reversal of CD8+T Cell Exhaustion: A Literature Review

CD8 T细胞耗竭的调控机制和逆转: 文献综述

IF3.5

2023-04-0112

OAAI

Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials

PARP抑制剂治疗BRCA突变乳腺癌的疗效和安全性: 一项更新的随机对照试验的系统评价和meta分析

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2023-03-091

OA

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer

人类癌症中肿瘤浸润T和b细胞的预后前景

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-049

OAAI

Metabolic checkpoints and novel approaches for immunotherapy against cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2021-10-218

OA

GNA14's interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway

IF2.9

2021-10-1718

OAAI

Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers

Fc融合T细胞受体的可溶性表达可产生新型双特异性T细胞衔接器

IF3.9

2021-07-083

OAAI

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

IF13.3

2020-01-0153

OAAI

Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis

IF15.8

2019-07-1755

OAAI

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression

RIP3通过控制肿瘤细胞增殖和CXCL1-induced免疫抑制促进结肠炎相关性结直肠癌

IF13.3

2019-01-0169

OAAI

Patient-oncologist alliance and psychosocial well-being in Chinese society strongly affect cancer management adherence with cancer of unknown primary

PSYCHO-ONCOLOGY

IF3.5

2016-09-204

PREAI